Report Details

List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Nuclear MedicineRadiopharmaceutic Market Size Comparison by Region (M USD)
Table 5. Global Nuclear MedicineRadiopharmaceutic Sales (K MT) by Manufacturers (2018-2023)
Table 6. Global Nuclear MedicineRadiopharmaceutic Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Nuclear MedicineRadiopharmaceutic Revenue (M USD) by Manufacturers (2018-2023)
Table 8. Global Nuclear MedicineRadiopharmaceutic Revenue Share by Manufacturers (2018-2023)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear MedicineRadiopharmaceutic as of 2022)
Table 10. Global Market Nuclear MedicineRadiopharmaceutic Average Price (USD/MT) of Key Manufacturers (2018-2023)
Table 11. Manufacturers Nuclear MedicineRadiopharmaceutic Sales Sites and Area Served
Table 12. Manufacturers Nuclear MedicineRadiopharmaceutic Product Type
Table 13. Global Nuclear MedicineRadiopharmaceutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Nuclear MedicineRadiopharmaceutic
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nuclear MedicineRadiopharmaceutic Market Challenges
Table 22. Market Restraints
Table 23. Global Nuclear MedicineRadiopharmaceutic Sales by Type (K MT)
Table 24. Global Nuclear MedicineRadiopharmaceutic Market Size by Type (M USD)
Table 25. Global Nuclear MedicineRadiopharmaceutic Sales (K MT) by Type (2018-2023)
Table 26. Global Nuclear MedicineRadiopharmaceutic Sales Market Share by Type (2018-2023)
Table 27. Global Nuclear MedicineRadiopharmaceutic Market Size (M USD) by Type (2018-2023)
Table 28. Global Nuclear MedicineRadiopharmaceutic Market Size Share by Type (2018-2023)
Table 29. Global Nuclear MedicineRadiopharmaceutic Price (USD/MT) by Type (2018-2023)
Table 30. Global Nuclear MedicineRadiopharmaceutic Sales (K MT) by Application
Table 31. Global Nuclear MedicineRadiopharmaceutic Market Size by Application
Table 32. Global Nuclear MedicineRadiopharmaceutic Sales by Application (2018-2023) & (K MT)
Table 33. Global Nuclear MedicineRadiopharmaceutic Sales Market Share by Application (2018-2023)
Table 34. Global Nuclear MedicineRadiopharmaceutic Sales by Application (2018-2023) & (M USD)
Table 35. Global Nuclear MedicineRadiopharmaceutic Market Share by Application (2018-2023)
Table 36. Global Nuclear MedicineRadiopharmaceutic Sales Growth Rate by Application (2018-2023)
Table 37. Global Nuclear MedicineRadiopharmaceutic Sales by Region (2018-2023) & (K MT)
Table 38. Global Nuclear MedicineRadiopharmaceutic Sales Market Share by Region (2018-2023)
Table 39. North America Nuclear MedicineRadiopharmaceutic Sales by Country (2018-2023) & (K MT)
Table 40. Europe Nuclear MedicineRadiopharmaceutic Sales by Country (2018-2023) & (K MT)
Table 41. Asia Pacific Nuclear MedicineRadiopharmaceutic Sales by Region (2018-2023) & (K MT)
Table 42. South America Nuclear MedicineRadiopharmaceutic Sales by Country (2018-2023) & (K MT)
Table 43. Middle East and Africa Nuclear MedicineRadiopharmaceutic Sales by Region (2018-2023) & (K MT)
Table 44. GE Healthcare Nuclear MedicineRadiopharmaceutic Basic Information
Table 45. GE Healthcare Nuclear MedicineRadiopharmaceutic Product Overview
Table 46. GE Healthcare Nuclear MedicineRadiopharmaceutic Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 47. GE Healthcare Business Overview
Table 48. GE Healthcare Nuclear MedicineRadiopharmaceutic SWOT Analysis
Table 49. GE Healthcare Recent Developments
Table 50. Bracco Imaging Nuclear MedicineRadiopharmaceutic Basic Information
Table 51. Bracco Imaging Nuclear MedicineRadiopharmaceutic Product Overview
Table 52. Bracco Imaging Nuclear MedicineRadiopharmaceutic Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 53. Bracco Imaging Business Overview
Table 54. Bracco Imaging Nuclear MedicineRadiopharmaceutic SWOT Analysis
Table 55. Bracco Imaging Recent Developments
Table 56. Mallinckrodt Nuclear MedicineRadiopharmaceutic Basic Information
Table 57. Mallinckrodt Nuclear MedicineRadiopharmaceutic Product Overview
Table 58. Mallinckrodt Nuclear MedicineRadiopharmaceutic Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 59. Mallinckrodt Business Overview
Table 60. Mallinckrodt Nuclear MedicineRadiopharmaceutic SWOT Analysis
Table 61. Mallinckrodt Recent Developments
Table 62. Lantheus Medical Imaging Nuclear MedicineRadiopharmaceutic Basic Information
Table 63. Lantheus Medical Imaging Nuclear MedicineRadiopharmaceutic Product Overview
Table 64. Lantheus Medical Imaging Nuclear MedicineRadiopharmaceutic Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 65. Lantheus Medical Imaging Business Overview
Table 66. Lantheus Medical Imaging Nuclear MedicineRadiopharmaceutic SWOT Analysis
Table 67. Lantheus Medical Imaging Recent Developments
Table 68. Bayer Nuclear MedicineRadiopharmaceutic Basic Information
Table 69. Bayer Nuclear MedicineRadiopharmaceutic Product Overview
Table 70. Bayer Nuclear MedicineRadiopharmaceutic Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 71. Bayer Business Overview
Table 72. Bayer Nuclear MedicineRadiopharmaceutic SWOT Analysis
Table 73. Bayer Recent Developments
Table 74. Jubilant Pharma Nuclear MedicineRadiopharmaceutic Basic Information
Table 75. Jubilant Pharma Nuclear MedicineRadiopharmaceutic Product Overview
Table 76. Jubilant Pharma Nuclear MedicineRadiopharmaceutic Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 77. Jubilant Pharma Business Overview
Table 78. Jubilant Pharma Recent Developments
Table 79. Nordion Nuclear MedicineRadiopharmaceutic Basic Information
Table 80. Nordion Nuclear MedicineRadiopharmaceutic Product Overview
Table 81. Nordion Nuclear MedicineRadiopharmaceutic Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 82. Nordion Business Overview
Table 83. Nordion Recent Developments
Table 84. Eli Lilly Nuclear MedicineRadiopharmaceutic Basic Information
Table 85. Eli Lilly Nuclear MedicineRadiopharmaceutic Product Overview
Table 86. Eli Lilly Nuclear MedicineRadiopharmaceutic Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 87. Eli Lilly Business Overview
Table 88. Eli Lilly Recent Developments
Table 89. SIEMENS Nuclear MedicineRadiopharmaceutic Basic Information
Table 90. SIEMENS Nuclear MedicineRadiopharmaceutic Product Overview
Table 91. SIEMENS Nuclear MedicineRadiopharmaceutic Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 92. SIEMENS Business Overview
Table 93. SIEMENS Recent Developments
Table 94. China Isotope and Radiation Nuclear MedicineRadiopharmaceutic Basic Information
Table 95. China Isotope and Radiation Nuclear MedicineRadiopharmaceutic Product Overview
Table 96. China Isotope and Radiation Nuclear MedicineRadiopharmaceutic Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 97. China Isotope and Radiation Business Overview
Table 98. China Isotope and Radiation Recent Developments
Table 99. Yantai Dongcheng Biochemicals Nuclear MedicineRadiopharmaceutic Basic Information
Table 100. Yantai Dongcheng Biochemicals Nuclear MedicineRadiopharmaceutic Product Overview
Table 101. Yantai Dongcheng Biochemicals Nuclear MedicineRadiopharmaceutic Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 102. Yantai Dongcheng Biochemicals Business Overview
Table 103. Yantai Dongcheng Biochemicals Recent Developments
Table 104. Global Nuclear MedicineRadiopharmaceutic Sales Forecast by Region (2024-2029) & (K MT)
Table 105. Global Nuclear MedicineRadiopharmaceutic Market Size Forecast by Region (2024-2029) & (M USD)
Table 106. North America Nuclear MedicineRadiopharmaceutic Sales Forecast by Country (2024-2029) & (K MT)
Table 107. North America Nuclear MedicineRadiopharmaceutic Market Size Forecast by Country (2024-2029) & (M USD)
Table 108. Europe Nuclear MedicineRadiopharmaceutic Sales Forecast by Country (2024-2029) & (K MT)
Table 109. Europe Nuclear MedicineRadiopharmaceutic Market Size Forecast by Country (2024-2029) & (M USD)
Table 110. Asia Pacific Nuclear MedicineRadiopharmaceutic Sales Forecast by Region (2024-2029) & (K MT)
Table 111. Asia Pacific Nuclear MedicineRadiopharmaceutic Market Size Forecast by Region (2024-2029) & (M USD)
Table 112. South America Nuclear MedicineRadiopharmaceutic Sales Forecast by Country (2024-2029) & (K MT)
Table 113. South America Nuclear MedicineRadiopharmaceutic Market Size Forecast by Country (2024-2029) & (M USD)
Table 114. Middle East and Africa Nuclear MedicineRadiopharmaceutic Consumption Forecast by Country (2024-2029) & (Units)
Table 115. Middle East and Africa Nuclear MedicineRadiopharmaceutic Market Size Forecast by Country (2024-2029) & (M USD)
Table 116. Global Nuclear MedicineRadiopharmaceutic Sales Forecast by Type (2024-2029) & (K MT)
Table 117. Global Nuclear MedicineRadiopharmaceutic Market Size Forecast by Type (2024-2029) & (M USD)
Table 118. Global Nuclear MedicineRadiopharmaceutic Price Forecast by Type (2024-2029) & (USD/MT)
Table 119. Global Nuclear MedicineRadiopharmaceutic Sales (K MT) Forecast by Application (2024-2029)
Table 120. Global Nuclear MedicineRadiopharmaceutic Market Size Forecast by Application (2024-2029) & (M USD)
List of Figures
Figure 1. Product Picture of Nuclear MedicineRadiopharmaceutic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nuclear MedicineRadiopharmaceutic Market Size (M USD), 2018-2029
Figure 5. Global Nuclear MedicineRadiopharmaceutic Market Size (M USD) (2018-2029)
Figure 6. Global Nuclear MedicineRadiopharmaceutic Sales (K MT) & (2018-2029)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nuclear MedicineRadiopharmaceutic Market Size by Country (M USD)
Figure 11. Nuclear MedicineRadiopharmaceutic Sales Share by Manufacturers in 2022
Figure 12. Global Nuclear MedicineRadiopharmaceutic Revenue Share by Manufacturers in 2022
Figure 13. Nuclear MedicineRadiopharmaceutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 Vs 2022
Figure 14. Global Market Nuclear MedicineRadiopharmaceutic Average Price (USD/MT) of Key Manufacturers in 2022
Figure 15. The Global 5 and 10 Largest Players: Market Share by Nuclear MedicineRadiopharmaceutic Revenue in 2022
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Nuclear MedicineRadiopharmaceutic Market Share by Type
Figure 18. Sales Market Share of Nuclear MedicineRadiopharmaceutic by Type (2018-2023)
Figure 19. Sales Market Share of Nuclear MedicineRadiopharmaceutic by Type in 2022
Figure 20. Market Size Share of Nuclear MedicineRadiopharmaceutic by Type (2018-2023)
Figure 21. Market Size Market Share of Nuclear MedicineRadiopharmaceutic by Type in 2022
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Nuclear MedicineRadiopharmaceutic Market Share by Application
Figure 24. Global Nuclear MedicineRadiopharmaceutic Sales Market Share by Application (2018-2023)
Figure 25. Global Nuclear MedicineRadiopharmaceutic Sales Market Share by Application in 2022
Figure 26. Global Nuclear MedicineRadiopharmaceutic Market Share by Application (2018-2023)
Figure 27. Global Nuclear MedicineRadiopharmaceutic Market Share by Application in 2022
Figure 28. Global Nuclear MedicineRadiopharmaceutic Sales Growth Rate by Application (2018-2023)
Figure 29. Global Nuclear MedicineRadiopharmaceutic Sales Market Share by Region (2018-2023)
Figure 30. North America Nuclear MedicineRadiopharmaceutic Sales and Growth Rate (2018-2023) & (K MT)
Figure 31. North America Nuclear MedicineRadiopharmaceutic Sales Market Share by Country in 2022
Figure 32. U.S. Nuclear MedicineRadiopharmaceutic Sales and Growth Rate (2018-2023) & (K MT)
Figure 33. Canada Nuclear MedicineRadiopharmaceutic Sales (K MT) and Growth Rate (2018-2023)
Figure 34. Mexico Nuclear MedicineRadiopharmaceutic Sales (Units) and Growth Rate (2018-2023)
Figure 35. Europe Nuclear MedicineRadiopharmaceutic Sales and Growth Rate (2018-2023) & (K MT)
Figure 36. Europe Nuclear MedicineRadiopharmaceutic Sales Market Share by Country in 2022
Figure 37. Germany Nuclear MedicineRadiopharmaceutic Sales and Growth Rate (2018-2023) & (K MT)
Figure 38. France Nuclear MedicineRadiopharmaceutic Sales and Growth Rate (2018-2023) & (K MT)
Figure 39. U.K. Nuclear MedicineRadiopharmaceutic Sales and Growth Rate (2018-2023) & (K MT)
Figure 40. Italy Nuclear MedicineRadiopharmaceutic Sales and Growth Rate (2018-2023) & (K MT)
Figure 41. Russia Nuclear MedicineRadiopharmaceutic Sales and Growth Rate (2018-2023) & (K MT)
Figure 42. Asia Pacific Nuclear MedicineRadiopharmaceutic Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Nuclear MedicineRadiopharmaceutic Sales Market Share by Region in 2022
Figure 44. China Nuclear MedicineRadiopharmaceutic Sales and Growth Rate (2018-2023) & (K MT)
Figure 45. Japan Nuclear MedicineRadiopharmaceutic Sales and Growth Rate (2018-2023) & (K MT)
Figure 46. South Korea Nuclear MedicineRadiopharmaceutic Sales and Growth Rate (2018-2023) & (K MT)
Figure 47. India Nuclear MedicineRadiopharmaceutic Sales and Growth Rate (2018-2023) & (K MT)
Figure 48. Southeast Asia Nuclear MedicineRadiopharmaceutic Sales and Growth Rate (2018-2023) & (K MT)
Figure 49. South America Nuclear MedicineRadiopharmaceutic Sales and Growth Rate (K MT)
Figure 50. South America Nuclear MedicineRadiopharmaceutic Sales Market Share by Country in 2022
Figure 51. Brazil Nuclear MedicineRadiopharmaceutic Sales and Growth Rate (2018-2023) & (K MT)
Figure 52. Argentina Nuclear MedicineRadiopharmaceutic Sales and Growth Rate (2018-2023) & (K MT)
Figure 53. Columbia Nuclear MedicineRadiopharmaceutic Sales and Growth Rate (2018-2023) & (K MT)
Figure 54. Middle East and Africa Nuclear MedicineRadiopharmaceutic Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Nuclear MedicineRadiopharmaceutic Sales Market Share by Region in 2022
Figure 56. Saudi Arabia Nuclear MedicineRadiopharmaceutic Sales and Growth Rate (2018-2023) & (K MT)
Figure 57. UAE Nuclear MedicineRadiopharmaceutic Sales and Growth Rate (2018-2023) & (K MT)
Figure 58. Egypt Nuclear MedicineRadiopharmaceutic Sales and Growth Rate (2018-2023) & (K MT)
Figure 59. Nigeria Nuclear MedicineRadiopharmaceutic Sales and Growth Rate (2018-2023) & (K MT)
Figure 60. South Africa Nuclear MedicineRadiopharmaceutic Sales and Growth Rate (2018-2023) & (K MT)
Figure 61. Global Nuclear MedicineRadiopharmaceutic Sales Forecast by Volume (2018-2029) & (K MT)
Figure 62. Global Nuclear MedicineRadiopharmaceutic Market Size Forecast by Value (2018-2029) & (M USD)
Figure 63. Global Nuclear MedicineRadiopharmaceutic Sales Market Share Forecast by Type (2024-2029)
Figure 64. Global Nuclear MedicineRadiopharmaceutic Market Share Forecast by Type (2024-2029)
Figure 65. Global Nuclear MedicineRadiopharmaceutic Sales Forecast by Application (2024-2029)
Figure 66. Global Nuclear MedicineRadiopharmaceutic Market Share Forecast by Application (2024-2029)